
How a phased CRO partnership built on ICH E6(R2) and E6(R3) principles supported a multi-indication biotech portfolio.

Janel Shelton-DeMagnus serves as senior director of clinical operations at Navitas Life Sciences, bringing multiple years of experience in clinical research and clinical practice as a physician assistant. Her expertise spans clinical operations, quality by design, risk-based trial oversight, and strategic study delivery, helping sponsors navigate increasingly complex clinical development programs while maintaining a strong focus on patient safety and data quality.

How a phased CRO partnership built on ICH E6(R2) and E6(R3) principles supported a multi-indication biotech portfolio.